Publications by authors named "Touko Inao"

Claim this Profile
D
Different sensitivities of senescent breast cancer cells to immune cell-mediated cytotoxicity.
Touko Inao, Hitoshi Kotani, Yuichi Iida, Irna Diyana Kartika, Tamio Okimoto

Cancer Sci· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor-positive/human epidermal growth factor receptor type 2 negative breast cancer.
Yuichiro Miyoshi, Tadahiko Shien, Akiko Ogiya, Naoko Ishida, Kieko Yamazaki, Touko Inao

Oncol Lett· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicin.
Touko Inao, Yuichi Iida, Tamami Moritani, Tamio Okimoto, Ryosuke Tanino

Oncotarget· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer.
Akiko Ogiya, Kieko Yamazaki, Rie Horii, Tadahiko Shien, Yoshiya Horimoto, Touko Inao

Breast Cancer· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features of lenvatinib treatment in elderly patients with advanced thyroid cancer.
Koichi Suyama, Saori Fujiwara, Takashi Takeshita, Aiko Sueta, Touko Inao

Mol Clin Oncol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer.
Akiko Ogiya, Kieko Yamazaki, Rie Horii, Tadahiko Shien, Yoshiya Horimoto, Touko Inao

Breast Cancer· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.
Hiroko Yamashita, Akiko Ogiya, Tadahiko Shien, Yoshiya Horimoto, Norikazu Masuda, Touko Inao

Breast Cancer· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.
Yuichiro Miyoshi, Tadahiko Shien, Akiko Ogiya, Naoko Ishida, Kieko Yamazaki, Touko Inao

Breast Cancer Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer.
Mai Tomiguchi, Yutaka Yamamoto, Mutsuko Yamamoto-Ibusuki, Lisa Goto-Yamaguchi, Yoshitaka Fujiki, Touko Inao

Cancer Sci· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of sentinel lymph node status using single-photon emission computed tomography (SPECT)/computed tomography (CT) imaging of breast cancer.
Mai Tomiguchi, Mutsuko Yamamoto-Ibusuki, Yutaka Yamamoto, Mamiko Fujisue, Shinya Shiraishi, Touko Inao

Surg Today· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[A case of estrogen receptor-positive metastatic breast cancer in a postmenopausal woman treated with ethinyl estradiol].
Hitomi Goto, Touko Inao, Masahiro Nakano, Mutsuko Ibusuki, Keiichi Murakami

Gan To Kagaku Ryoho· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HSP70 and autophagy inhibitor pifithrin-μ enhances the antitumor effects of TRAIL on human pancreatic cancer.
Hiroyuki Monma, Nanae Harashima, Touko Inao, Shinji Okano, Yoshitsugu Tajima

Mol Cancer Ther· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo.
Miki Tongu, Nanae Harashima, Hiroyuki Monma, Touko Inao, Takaya Yamada

Cancer Immunol Immunother· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand, poly(I:C), on human breast cancer.
Touko Inao, Nanae Harashima, Hiroyuki Monma, Shinji Okano, Masayuki Itakura

Breast Cancer Res Treat· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: Correlation with tumor progression and prognosis.
Yasunari Kawabata, Tsuneo Tanaka, Takashi Nishisaka, Touko Inao, Takeshi Nishi

Diagn Pathol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis